Advances in multiple myeloma therapy during two past decades
Author:
Publisher
Elsevier BV
Subject
Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology
Reference28 articles.
1. Myeloma in patients under age 50 presents with more favorable features and shows better survival: an analysis of 10,549 patients from the International Myeloma Working Group;Ludwig;Blood,2008
2. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008
3. A phase 2 study of bortezomib in relapsed, refractory myeloma;Richardson;N Engl J Med,2003
4. Bortezomib or high-dose dexamethasone for relapsed multiple myeloma;Richardson;N Engl J Med,2005
5. The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications;Mitsiades;Blood,2003
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The effect of haemoglobin, albumin, lymphocyte and platelet score on the prognosis in patients with multiple myeloma;International Journal of Laboratory Hematology;2022-09-02
2. Significance of preoperative peripheral blood neutrophil-lymphocyte ratio in predicting postoperative survival in patients with multiple myeloma bone disease;World Journal of Clinical Cases;2022-05-16
3. AntagomiR-19a Induced Better Responsiveness to Bortezomib in Myeloma Cell Lines;CELL J;2021
4. Atypical Presentation of Plasma Cell Neoplasm of the Sternum;Cureus;2021-07-02
5. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?;Journal of Laboratory Physicians;2018-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3